Real-time enrollment status for this retinitis pigmentosa clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:23 PM UTC
| NCT Number | NCT07408232 |
| Recruiting Status | Recruiting |
| Condition | Retinitis Pigmentosa |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Octant, Inc. |
| Last Updated on CT.gov | September 24, 2026 (3 weeks ago) |
As of October 15, 2026: Clinical trial NCT07408232 is currently recruiting participants. This phase1 study for retinitis pigmentosa is actively seeking new participants at 2 locations across the United States. The study is sponsored by Octant, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07408232 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07408232 was last updated 3 weeks ago (September 24, 2026). HelloStudys verifies this status automatically.